Global Medical REIT Inc. (GMRE) P/E Ratio History
Historical price-to-earnings valuation from 2018 to 2025
Loading P/E history...
GMRE Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Global Medical REIT Inc. (GMRE) trades at a price-to-earnings ratio of 115.3x, with a stock price of $35.74 and trailing twelve-month earnings per share of $0.19.
The current P/E is 558% above its 5-year average of 17.5x. Over the past five years, GMRE's P/E has ranged from a low of 5.8x to a high of 61.0x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.3x, GMRE trades at a 374% premium to its sector peers. The sector includes 170 companies with P/E ratios ranging from 1.1x to 195.0x.
Relative to the broader market, GMRE commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GMRE DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
GMRE P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $500M | 226.2 | - | +134% | |
| $979M | 7.1Lowest | - | +1445%Best | |
| $14B | 195.0 | - | -72% | |
| $14B | 23.7 | 1.02Best | +25% | |
| $5B | 32.0 | - | +19% | |
| $2B | 15.3 | - | +24% | |
| $9B | 25.1 | 1.19 | +96% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
GMRE Historical P/E Data (2018–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $33.71 | $0.55 | 61.0x | +325% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $34.65 | $1.68 | 20.6x | +43% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $43.75 | $1.34 | 32.7x | +128% |
| FY2024 Q4 | $38.60 | $1.41 | 27.4x | +91% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $49.55 | $1.13 | 43.9x | +206% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $45.40 | $2.20 | 20.6x | +44% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $43.75 | $7.34 | 6.0x | -59% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $55.50 | $7.30 | 7.6x | -47% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $44.85 | $4.69 | 9.6x | -33% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $45.65 | $5.94 | 7.7x | -47% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $45.55 | $2.19 | 20.8x | +45% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $47.40 | $2.95 | 16.1x | +12% |
Average P/E for displayed period: 14.4x
See GMRE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GMRE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GMRE vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonGMRE — Frequently Asked Questions
Quick answers to the most common questions about buying GMRE stock.
Is GMRE stock overvalued or undervalued?
GMRE trades at 115.3x P/E, above its 5-year average of 17.5x. The 100th percentile ranking indicates a premium to historical valuation.
How does GMRE's valuation compare to peers?
Global Medical REIT Inc. P/E of 115.3x compares to sector median of 24.3x. The premium reflects expected growth above peers.
What is GMRE's PEG ratio?
GMRE PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2018-2025.